GR3032748T3 - Nutrition for persons infected with human immunodeficiency virus. - Google Patents

Nutrition for persons infected with human immunodeficiency virus.

Info

Publication number
GR3032748T3
GR3032748T3 GR20000400448T GR20000400448T GR3032748T3 GR 3032748 T3 GR3032748 T3 GR 3032748T3 GR 20000400448 T GR20000400448 T GR 20000400448T GR 20000400448 T GR20000400448 T GR 20000400448T GR 3032748 T3 GR3032748 T3 GR 3032748T3
Authority
GR
Greece
Prior art keywords
infected
immunodeficiency virus
human immunodeficiency
nutritional product
person
Prior art date
Application number
GR20000400448T
Other languages
English (en)
Inventor
Frederick Oliver Cope
Normanella Torres Dewille
Ernest William Richards
Bonnie Chandler Abbruzzese
Michael Allen Chandler
Gregory Allan Snowden
Terrence Bruce Mazer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/069,264 external-priority patent/US5330972A/en
Priority claimed from US08/069,269 external-priority patent/US5403826A/en
Priority claimed from US08/069,066 external-priority patent/US5480872A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of GR3032748T3 publication Critical patent/GR3032748T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR20000400448T 1993-05-28 2000-02-23 Nutrition for persons infected with human immunodeficiency virus. GR3032748T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/069,264 US5330972A (en) 1993-05-28 1993-05-28 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
US08/069,269 US5403826A (en) 1993-05-28 1993-05-28 Nutritional product for persons infected with human immunodeficiency virus
US08/069,066 US5480872A (en) 1993-05-28 1993-05-28 Method of providing enternal nutritional support to persons infected with human immunodeficiency virus

Publications (1)

Publication Number Publication Date
GR3032748T3 true GR3032748T3 (en) 2000-06-30

Family

ID=27371464

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400448T GR3032748T3 (en) 1993-05-28 2000-02-23 Nutrition for persons infected with human immunodeficiency virus.

Country Status (15)

Country Link
EP (1) EP0626177B1 (el)
JP (1) JPH089545B2 (el)
KR (1) KR970005330B1 (el)
AT (1) ATE187076T1 (el)
AU (1) AU651284B1 (el)
CA (1) CA2105790C (el)
DE (1) DE69327159T2 (el)
DK (1) DK0626177T3 (el)
ES (1) ES2142842T3 (el)
GR (1) GR3032748T3 (el)
IL (1) IL106975A (el)
NZ (1) NZ248603A (el)
PH (1) PH30682A (el)
PT (1) PT626177E (el)
TW (1) TW492867B (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US5759548A (en) 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH11512439A (ja) * 1995-09-14 1999-10-26 エルエックスアール バイオテクノロジー インコーポレイテッド リン脂質の混合物を含む抗アポトーシス活性を有する組成物
US5681600A (en) * 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
US5908862A (en) * 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5958974A (en) * 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
US5866606A (en) * 1996-07-31 1999-02-02 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents
DK0918742T3 (da) * 1996-07-31 2002-12-09 Abbott Lab Med vand blandbare estere af monoglycerider, som har anti-mikrobiel aktivitet
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US6194379B1 (en) * 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
EP1236405B1 (en) * 2001-03-01 2006-06-21 Societe Des Produits Nestle S.A. Hypoallergenic formulae inducing oral tolerance to soy proteins
EP1281325A1 (en) 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
JP4554149B2 (ja) * 2002-11-28 2010-09-29 雅美 森山 レトロウイルス感染症治療薬
DE602004005348T2 (de) * 2003-09-10 2007-07-12 Unilever N.V. Nahrungsmittelzusammensetzung
EP1723951A1 (en) † 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
PT1758469E (pt) * 2004-06-22 2010-02-03 Nutricia Nv Melhoria da integridade da barreira nos doentes com vih com o uso de ácidos gordos
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
JP5098198B2 (ja) * 2005-03-28 2012-12-12 大正製薬株式会社 銅化合物配合組成物
WO2007063143A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral
ES2584191T3 (es) * 2005-11-30 2016-09-26 Vegenat, S.A. Mezcla de proteínas y su utilización para preparar un producto destinado a la alimentación oral o enteral
EP1972345B1 (en) * 2005-11-30 2014-08-13 Vegenat, S.A. Food product for enteral or oral nutrition
BRPI0621285A2 (pt) * 2006-01-31 2011-12-06 Parsroos Co método para a preparação de um extrato vegetal e processo de produção de uma composição farmacêutica para estìmulo imunológico e/ou tratamento de infecções por hiv que compreende o referido extrato vegetal
JP5181486B2 (ja) * 2006-02-16 2013-04-10 大正製薬株式会社 亜鉛化合物配合経口用組成物
JP2007246509A (ja) * 2006-02-16 2007-09-27 Taisho Pharmaceut Co Ltd 銅化合物配合経口用組成物
CN102176835B (zh) * 2008-10-10 2015-07-22 索莱有限责任公司 高热量肠道制剂
WO2016035095A1 (en) * 2014-09-01 2016-03-10 Vadakkemuri Mathew Jolly Optimized nutrient food

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA86415B (en) * 1985-01-29 1986-09-24 Abbott Lab Enteral nutritional hypoallergenic formula
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DK3991D0 (da) * 1991-01-10 1991-01-10 Novo Nordisk As Fremgangsmaade til fremstilling af et proteinhydrolysat
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat

Also Published As

Publication number Publication date
JPH089545B2 (ja) 1996-01-31
JPH06340545A (ja) 1994-12-13
KR970005330B1 (ko) 1997-04-15
EP0626177B1 (en) 1999-12-01
DE69327159D1 (de) 2000-01-05
IL106975A0 (en) 1993-12-28
CA2105790A1 (en) 1994-11-29
PH30682A (en) 1997-09-16
CA2105790C (en) 1998-07-28
EP0626177A2 (en) 1994-11-30
DE69327159T2 (de) 2000-07-13
DK0626177T3 (da) 2000-05-08
ATE187076T1 (de) 1999-12-15
ES2142842T3 (es) 2000-05-01
IL106975A (en) 1996-01-19
AU651284B1 (en) 1994-07-14
TW492867B (en) 2002-07-01
PT626177E (pt) 2000-05-31
NZ248603A (en) 1994-12-22
EP0626177A3 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
GR3032748T3 (en) Nutrition for persons infected with human immunodeficiency virus.
CA2372614A1 (en) Process and product for enhancing immune response in companion animal using a combination of antioxidants
DE69331528D1 (de) Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
CA2105791A1 (en) Nutrition for Persons Undergoing Radiation Therapy and/or Chemotherapy
ATE88631T1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
CA2373801A1 (en) Gelled nutritional composition and process
WO1988003150A3 (fr) Preparations aminoacides contenant des peptides de n,n'-bis-l-aminoacide-l-cystine et destinees a l'administration orale et parenterale
ATE178615T1 (de) Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen
AU7045091A (en) Nutritionally complete enteral diet product
McBride Agnotes: Don't Overdo the Vitamin A
Guembel Change of arachidonic acid and docosa-hexaen acid speculum in the serum of people having heart trouble on a coronary diet with mackerel.).
Kojima Gastrointestinal absorption of cadmium.
TH8505EX (th) ที่ป้อนน้ำผลไม้
Brunet Vitamin B-6 intake and blood levels in breast-and formula-fed infants
TH13901EX (th) ผลไม้ประดิษฐ์
TH13908EX (th) ผลไม้ประดิษฐ์
TH13906EX (th) ผลไม้ประดิษฐ์
TH13910EX (th) ผลไม้ประดิษฐ์
TH13905EX (th) ผลไม้ประดิษฐ์
TH13904EX (th) ผลไม้ประดิษฐ์
TH13902EX (th) ผลไม้ประดิษฐ์
TH13911EX (th) ผลไม้ประดิษฐ์
TH13900EX (th) ผลไม้ประดิษฐ์
TH13907EX (th) ผลไม้ประดิษฐ์
TH13909EX (th) ผลไม้ประดิษฐ์

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees